Quality Assurance of Pharmaceuticals - A Compendium of Guidelines and Related Materials - Volume 1
(1997; 248 pages) [French] View the PDF document
Table of Contents
Open this folder and view contentsIntroduction
Open this folder and view contents1. National drug regulation
Open this folder and view contents2. Product assessment and registration
Close this folder3. Distribution
Close this folderQuality assurance in pharmaceutical supply systems1
View the document1. Introduction and general considerations
Open this folder and view contents2. Elements of quality assessment and assurance
Close this folder3. Pre-marketing quality assessment
View the document3.1 Drug notification, authorization and registration
View the document3.2 Drug nomenclature
Open this folder and view contents4. Drug quality surveillance during marketing
View the documentReferences
Open this folder and view contents4. The international pharmacopoeia and related activities
Open this folder and view contents5. Basic tests
Open this folder and view contents6. Laboratory services
Open this folder and view contents7. International trade in pharmaceuticals
Open this folder and view contents8. Counterfeit products
Open this folder and view contents9. Training
View the documentSelected WHO publications of related interest
View the documentBack cover
 
3.2 Drug nomenclature

The need to identify each pharmaceutical substance by a unique and universally applicable nonproprietary name has long been recognized. WHO is carrying out a programme on the standardization of drug nomenclature and has published International Nonproprietary Names (INN) for over 4000 pharmaceutical substances.1 Comprehensive information on the programme can be found in the twentieth report of the WHO Expert Committee on Nonproprietary Names for Pharmaceutical Substances (10).

1 INN for over 6800 pharmaceutical substances have now been published (see inside back cover for details of the latest cumulative list).

When a new drug is introduced into a country, the active ingredients should be properly identified on the label by INN or, if these are not available, by other established nonproprietary names. The names in question should also be used in all official texts.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014